Related by context. All words. (Click for frequent words.) 79 FDA Approvals 77 Meets Primary Endpoint 77 Investigational Treatment 76 Prostate Cancer Vaccine 76 Phase IIb Trial 76 Rotavirus Vaccine 75 Investigational Drug 75 IND Application 75 Combination Treatment 75 Phase 2b Clinical Trial 74 Epilepsy Drug 74 FDA Accepts 74 Long Term Efficacy 74 Combo Therapy 74 Drug Candidate 74 Transdermal Patch 74 Investigational Compound 74 Expanded Indication 74 Gout Drug 74 Lupus Drug 74 Generic Versions 74 Demonstrates Positive 74 Treated Patients 74 Seasonal Influenza Vaccine 73 Pivotal Phase III 73 Patients Treated With 73 Submits NDA 73 Phase 2b Study 73 Fast Track Status 73 Initiates Clinical 73 Schizophrenia Drug 73 Clinical Trial Results 73 Diagnostic Tests 73 Cholesterol Lowering Drug 73 Study Evaluating 73 JAK Inhibitor 73 Advanced Melanoma 73 Phase IIb Clinical Trial 73 Topical Treatment 73 Pooled Analysis 73 Investigational Agent 73 Phase III Clinical Trial 73 NDA Submission 73 Positive Opinion 73 Patients Receiving 73 Smallpox Vaccine 72 FDA Clears 72 Receives Orphan Drug Designation 72 Prolongs Survival 72 Patient Enrollment 72 Initiate Clinical Trial 72 FDA Okays 72 Shows Efficacy 72 Generic Version 72 Schizophrenia Treatment 72 Improves Outcomes 72 Psoriasis Drug 72 Phase 2a Trial 72 Adjunctive Therapy 72 Study Showed 72 Rheumatoid Arthritis Patients 72 Demonstrates Efficacy 72 HCV Protease Inhibitor 72 Sustained Efficacy 72 Anticancer Drug 72 Improves Survival 72 Complicated Skin 72 Lung Cancer Drug 72 Phase 2b Trial 72 Phase IIa Clinical Trial 72 Drug Combo 72 Initiates Phase III 72 Ebola Vaccine 72 Mylan Receives Approval 72 Blood Pressure Drug 72 Drug Fails 72 Proven Effective 72 Clinical Trial Evaluating 72 Appears Safe 72 Pulmonary Arterial Hypertension 72 Nicotine Vaccine 71 Adjuvant Chemotherapy 71 Severe Sepsis 71 Preclinical Data 71 Osteoporosis Treatment 71 Novel Antibiotic 71 Beta Blocker 71 Rheumatoid Arthritis Drug 71 Demonstrates Potent 71 Adjuvant Treatment 71 Partial Onset Seizures 71 Blood Thinner 71 Generic Version Of 71 Files IND 71 Hepatitis B Vaccine 71 Single Dose 71 Myeloma Patients 71 Is Well Tolerated 71 Pafuramidine 71 Improved Survival 71 Pivotal Study 71 Completes Patient Enrollment 71 Vaccine Candidate 71 Anti Inflammatory Drug 71 Multiple Myeloma Patients 71 Heart Failure Patients 71 Pediatric Patients 71 Cocaine Addiction 71 Cholesterol Drug 71 Relapsing Multiple Sclerosis 71 Disease Modifying 71 Initiates Clinical Trial 71 IIa Clinical Trial 71 Treating Chronic 71 Acute Attacks 71 Granted Orphan Drug 71 Arthritis Drug 71 Shingles Vaccine 70 FDA APPROVES 70 Glatiramer Acetate 70 Patients Suffering 70 Nebulized 70 Statistically Significant 70 Phase III Trial 70 Phase III Trials 70 Fungal Infections 70 Pharmacokinetic Study 70 Kidney Transplant Patients 70 Chronic Sinusitis 70 Elderly Patients 70 Survival Benefit 70 Begin Clinical Trials 70 Lung Cancer Patients 70 Treating Heart Failure 70 Efficacy Trial 70 Slow Progression 70 IND Filing 70 Chronic Renal Failure 70 Osteoporosis Drug 70 Overactive Bladder 70 Hospital Acquired Pneumonia 70 Prostate Cancer Patients 70 Patients Undergoing 70 Anticoagulant 70 Demonstrated Significant 70 Renal Impairment 70 Demonstrates Statistically Significant 70 Novel Treatments 70 Teva Provides Update 70 Hormone Refractory Prostate Cancer 70 Atomoxetine 70 Antifungal 70 Extended Release 70 Treatment Naive Patients 70 FDA Panel Recommends 70 Pivotal Trials 70 Immunosuppressant 70 Cervical Cancer Vaccine 70 Drug Shows Promise 70 Tyrosine Kinase Inhibitor 70 Successfully Completes Phase 69 Reduces Mortality 69 Metastatic Melanoma 69 Topical Gel 69 Oral Insulin 69 Fewer Side Effects 69 PDUFA Date 69 Showed Significant 69 Fondaparinux 69 Breast Cancer Recurrence 69 dual endothelin receptor antagonist 69 Hematopoietic Stem Cell Transplantation 69 Melphalan 69 Non Invasive Treatment 69 Diabetic Neuropathy 69 Renal Cell Carcinoma 69 Efficacious 69 FDA Clearance 69 Shows Promising 69 Anticancer Agent 69 Infected Patients 69 ARIXTRA R 69 Anemia Drug 69 Clinical Outcome 69 Treatment Reduces 69 Dose Ranging Study 69 NICE Recommends 69 Therapeutic Vaccine 69 Trial Evaluating 69 Resistant Hypertension 69 Milestone Payment From 69 HER2 Positive Breast Cancer 69 Antitumor Activity 69 Patient Enrolment 69 Oral Fingolimod 69 Shows Promise Against 69 Less Invasive 69 Inhaled Nitric Oxide 69 Inhaled Insulin 69 Postmenopausal Osteoporosis 69 Knee Osteoarthritis 69 Pneumococcal Vaccine 69 Completes Enrollment 69 Minimally Invasive Treatment 69 Hepatitis C Treatment 69 Metastatic Colorectal Cancer 69 Prophylactic Treatment 69 Receives Approvable Letter 69 Mycophenolate Mofetil 69 Taro Receives 69 Phase 2a Clinical Trial 69 Epilepsy Drugs 69 Critically Ill Patients 69 ANDA Filing 69 Effectively Treats 69 Pain Relievers 69 Receives Positive Opinion 69 Controlled Study 69 Initiate Phase III 69 Silicone Breast Implants 69 SFDA Approval 69 Low Dose 69 Dose Escalation 69 Novel Oral 69 Initiate Phase 69 Drug Resistant 69 See CLINICAL PHARMACOLOGY 69 Confirmatory Phase 69 Phase 1b Clinical Trial 69 Soft Tissue Sarcoma 69 Clinical Trial Data 69 Testosterone Gel 69 Asthma Treatment 69 Presents Preclinical Data 69 Significantly Improved 69 Orphan Status 69 Therapeutic Antibody 69 Chronic Hepatitis B 69 Inhaled Corticosteroids 69 Files Investigational 69 Migraine Drug 69 Erectile Dysfunction Drug 69 Newly Diagnosed Multiple Myeloma 69 Sagent Pharmaceuticals Announces 69 First Patient Dosed 68 Plus Ribavirin 68 Previously Treated 68 Hypertensive Patients 68 Tablet Formulation 68 Malaria Vaccine 68 Demonstrates Significant 68 Stem Cell Treatment 68 Novel Inhibitor 68 Community Acquired Pneumonia 68 Interferon Beta 68 Milestone Payment 68 Diuretic 68 Breast Cancer Treatment 68 FDA Approves Drug 68 Subgroup Analysis 68 Vaccine Adjuvant 68 Myelodysplastic Syndromes 68 Chronic Heart Failure 68 HER2 Positive 68 Tuberculosis Vaccine 68 Initiates Phase II 68 Anticancer Activity 68 Improve Survival 68 Premature Infants 68 Desvenlafaxine Succinate 68 Companion Diagnostic 68 Well Tolerated 68 Patients Treated 68 Stronger Warnings 68 Receives Orphan Drug 68 Migraine Treatment 68 Experimental Vaccine 68 Peginterferon 68 Present Preclinical Data 68 Potentially Fatal 68 Significantly Reduced 68 Lung Cancer Survival 68 Mouse Model 68 Universal Flu Vaccine 68 Shown Effective 68 Recommends Approval 68 Adjunctive 68 Mg Usa 68 Hypercholesterolemia 68 Supplemental Biologics License Application 68 Mimetics 68 Initiates Phase 2b 68 Male Contraceptive 68 Resubmission 68 ACE Inhibitors 68 Breast Cancer Cells 68 Respiratory Virus 68 Vicriviroc 68 Hepatocellular Carcinoma 68 Molecular Diagnostic Test 68 Ranolazine 68 Secondary Hyperparathyroidism 68 Invasive Breast Cancer 68 Fixed Dose 68 TB Vaccine 68 Phase III Pivotal Trial 68 Bosutinib 68 Sodium Injection 68 Posaconazole 68 Peginterferon Alfa 2a 68 Disease Progression 68 Orthostatic Hypotension 68 Antiplatelet 68 Dupuytren Contracture 68 Metabolic Disorder 68 Treatment Regimen 68 II Clinical Trial 68 Urinary Tract Infections 68 Oral Calcitonin 68 Kidney Transplant Recipients 68 Data Suggest 68 Cognitive Impairment 68 Loxapine 68 Malignant Glioma 68 Acute Heart Failure 68 Prospective Randomized 68 Monotherapy 68 Kidney Function 68 Lung Infections 68 Invasive Fungal Infections 68 Antiepileptic Drug 68 Combination Vaccine 68 Bone Fracture 67 Antiviral Drugs 67 Capsules CII 67 Diabetic Nephropathy 67 Phase III Clinical Trials 67 Presents Positive 67 Benign Prostatic Hyperplasia 67 Heartburn Drugs 67 Enlarged Prostate 67 Pivotal Clinical Trial 67 Suicidality 67 Respiratory Syncytial Virus 67 Rotavirus Vaccines 67 H#N# Influenza Vaccine 67 Potent Antiviral Activity 67 Patient Outcomes 67 Prolongs Life 67 Gastric Cancer 67 Asthma Inhaler 67 CLINICAL PHARMACOLOGY 67 Node Positive 67 Faropenem 67 Treatment Shows Promise 67 Placebo Controlled Study 67 Expedited Review 67 Naive Patients 67 Diamyd Medical Diamyd 67 Venous Thromboembolism 67 Interferon Gamma 67 Biologic Drugs 67 Myoblast 67 Radiofrequency Ablation RFA 67 Hepatitis C Patients 67 Pegylated 67 Demonstrate Significant 67 Oral Cladribine 67 Sustained Reduction 67 Diagnostic Criteria 67 Osteoporosis Drugs 67 RNAi Therapeutic 67 Cholesterol Lowering 67 Vaginal Gel 67 Clinical Efficacy 67 Protease Inhibitor 67 Montelukast 67 CDC Recommends 67 Receives FDA Clearance 67 Bipolar Mania 67 STELARA TM 67 Diabetic Foot Ulcer 67 Anti Tumor 67 Inhalation Solution 67 Lowers Risk 67 Therapy Evaluation 67 Weight Loss Drug 67 Refractory Angina 67 Clinical Evaluation 67 Therapy Improves 67 Renal Function 67 Double Blind Randomized 67 Relapsed Refractory 67 Novel Mechanism 67 Reduces Pain 67 Advanced Prostate Cancer 67 Test Detects 67 Bloodstream Infections 67 Guidelines Issued 67 Seasonal Influenza 67 First Patient Enrolled 67 Vaccine Shows Promise 67 Advanced Colorectal Cancer 67 Multiple Ascending Dose 67 Humanized Anti 67 First Patient Treated 67 Pivotal Phase 67 Noxafil 67 Gene Therapy Trial 67 Osteoarthritis Pain 67 Initiates Enrollment 67 Drug Prevents 67 Tigecycline 67 Telithromycin 67 Inflammatory Arthritis 67 Immune Mediated 67 Successfully Treated 67 Oral Cavity 67 MRSA Infections 67 Human Monoclonal Antibody 67 Genes Linked 67 Arthritis Drugs 67 Fluconazole 67 Statin Drugs 67 Bone Marrow Transplants 67 Tezampanel 67 Colorectal Cancer Patients 67 Juvenile Idiopathic Arthritis 67 Treatment Resistant 67 Vitrasert R 67 Chronic Myeloid Leukemia 67 Atypical Antipsychotic 67 Combination REOLYSIN R 67 Obtains CE Mark 67 Skeletal Muscle 67 Chronic Hepatitis C 67 Inflammatory Markers 67 Novel Compound 67 Replacement Therapy 67 CHMP Opinion 67 Linezolid 67 #mg Tablets [002] 67 Randomized Double Blind 67 Antibiotic Resistant 67 Corneal Transplant 67 Dual Antiplatelet Therapy 67 Severe Asthma 67 RNAi Therapeutics 67 Liver Failure 67 Anti Nausea 67 Toremifene 67 Paliperidone Palmitate 67 Preclinical Study 67 Systemic Sclerosis 67 Prostate Cancer Treatment 67 Early Diagnosis 67 Intravitreal 67 Oral Formulation 67 Treatment Experienced 67 Parathyroid Hormone 67 Muscle Wasting 67 VIVITROL ® 67 Septic Shock 67 Seasonal Flu Vaccine 67 Monoclonal Antibody 67 Boxed Warnings 67 Sinus Infections 67 Antipsychotic Drug 67 Multicenter Trial 67 Biomarker Study 67 Darunavir 67 Achieves Primary Endpoint 66 Hip Fractures 66 Begins Dosing 66 Aliskiren 66 Newly Diagnosed Patients 66 Atypical Antipsychotics 66 Post Operative 66 Diabetic Patients 66 Pivotal Trial 66 Dendritic Cells 66 Generalized Anxiety Disorder 66 Estrogen Therapy 66 Non Inferiority 66 Transdermal Delivery 66 Elagolix 66 Full Prescribing Information 66 Develop Novel 66 Cancer Treatments 66 Lupus Nephritis 66 Vaccine Protects Against 66 Placebo Controlled Trial 66 Meta Analysis 66 Arterial Disease 66 Randomized Clinical Trial 66 Treat Heart Failure 66 Maleate 66 Acne Drug 66 Dengue Virus 66 Commercialize Novel 66 Peripheral Arterial 66 Avian Flu Vaccine 66 Pandemic Flu Vaccine 66 PRN FDA Approves 66 Cardiovascular Outcomes 66 Fracture Risk 66 Improve Diagnosis 66 Bronchodilator 66 Tyrosine Kinase Inhibitors 66 Blood Disorder 66 Bipolar Depression 66 Aurora Kinase 66 Fluticasone 66 Demonstrates Sustained 66 MMR Vaccine 66 Atopic Dermatitis 66 Pemetrexed 66 Combination Therapy 66 Approvable 66 NAVISTAR R 66 Angiogenic 66 Double Blind Placebo 66 Shows Statistically Significant 66 Neoadjuvant Chemotherapy 66 Eszopiclone 66 Confirms Efficacy 66 Diastolic Heart Failure 66 HCV Genotype 66 TNF Blockers 66 JAK2 Inhibitor 66 Postmenopausal Women 66 Zoledronic Acid 66 Gets FDA Clearance 66 Refractory Hodgkin Lymphoma 66 FDA Approvable Letter 66 Clinical Trial Enrollment 66 Therapy Reduces 66 Bacterial Infection 66 Elevated Levels 66 Ovarian Cancer Patients 66 Malignant Melanoma 66 Parenteral Nutrition 66 Sleep Disturbances 66 Polymerase Inhibitor 66 Genetic Tests 66 Differential Diagnosis 66 Valopicitabine 66 Insulin Glargine 66 Testosterone Patch 66 Pharmacokinetics PK 66 Treatment Naïve Patients 66 Collaborators Present 66 Liver Injury 66 Could Predict 66 FULL PRESCRIBING INFORMATION 66 Virus Linked 66 Bazedoxifene 66 Tiotropium 66 Gene Variant 66 Proves Effective 66 Oral Interferon 66 Genentech Provides Update 66 Minimally Invasive Procedure 66 Cardiotoxicity 66 Sapacitabine 66 Fabry Disease 66 Transplant Patients 66 Immunologic 66 Allergic Rhinitis 66 1mg 2mg 66 Chemoradiation 66 Antitumor 66 Novel Therapies 66 Peginterferon alfa 2b 66 Protein Linked 66 Anthrax Vaccine 66 Slows Progression 66 Pandemic Influenza Vaccine 66 ST Elevation Myocardial 66 Lanthanum Carbonate 66 Anti Clotting Drug 66 Cell Transplants 66 ANN INTERN MED 66 Late Breaker 66 aripiprazole Abilify 66 Enrolling Patients 66 Ecallantide 66 TOPAMAX R 66 Protease Inhibitors 66 Metastatic Prostate Cancer 66 Significant Improvements 66 Adjuvanted 66 Therapeutic Potential 66 Carbamazepine 66 Percutaneous Tibial Nerve Stimulation 66 Aztreonam Lysine 66 Inhaled Steroids 66 Antiviral Drug 66 Blocked Arteries 66 Stakeholder Opinions 66 Dry Powder Inhaler 66 Clinically Significant 66 Adjuvant Therapy 66 Oral Mucositis 66 Vaccine Trial 66 Preclinical Models 66 Vildagliptin 66 Immune Responses 65 Drug Approvals 65 Embolic Protection 65 Inhalation Aerosol 65 Hemodialysis Patients 65 Contraindications 65 Golimumab 65 Lung Cancer Trial 65 Efficacy Results 65 Drug Combinations 65 Urinary Incontinence 65 Receptor Agonist 65 Pegloticase 65 Heart Stents 65 Left Ventricular 65 Meningitis Vaccine 65 Tumor Growth 65 Reduces Risk 65 Renal Anemia 65 Submits Supplemental 65 Autologous Stem Cell Transplantation 65 Tumor Response 65 Pivotal Phase II 65 Tesamorelin 65 Drug Coated Stent 65 Stress Urinary Incontinence 65 FDA Approves Generic 65 Cholesterol Drugs 65 Gene Linked 65 Viral Infection 65 Novel Therapeutic 65 Janssen Risperdal 65 Lung Cancer Treatment 65 Initiate Phase II 65 Pediatric Asthma 65 Romidepsin 65 Predict Risk 65 ISTODAX ® 65 Improve Patient Safety 65 myelodysplastic myeloproliferative diseases 65 Significant Reduction 65 Iluvien TM 65 Moxifloxacin 65 Gene Mutation 65 Announces FDA Clearance 65 Bivalirudin 65 Bosentan 65 Pain Medication 65 Acute Pancreatitis 65 Eculizumab 65 Bone Metastases 65 Cancidas 65 Statin Therapy 65 Treat Anemia 65 Romiplostim 65 Package Insert 65 Antiviral Activity 65 Study Casts Doubt 65 Improve Outcomes 65 Artery Disease 65 Effective Than 65 VIVUS Announces 65 Increases Risk 65 Topical Cream 65 Anti Tumor Activity 65 Smooth Muscle 65 LibiGel ® 65 Intracerebral Hemorrhage 65 Pneumonia Vaccine 65 Aortic Valve 65 Receives Fast Track 65 Pegylated Interferon 65 Plaque Psoriasis 65 Fluvastatin 65 Prove Effective 65 oral dual endothelin 65 Phase Ib Clinical Trial 65 Osteoarthritis Patients 65 Beneficial Effects 65 Systemic Delivery 65 Kinase Inhibitor 65 ONGLYZA TM 65 Whooping Cough Vaccine 65 Valproic Acid 65 Preterm Infants 65 Migraine Headaches 65 ORLive Presents 65 HDAC Inhibitor 65 Proton Pump Inhibitor 65 Sprycel dasatinib 65 Initiates Phase 65 Molecular Diagnostic 65 Anticancer Compound 65 Drug Coated Stents 65 Lubiprostone 65 Squamous Cell Carcinoma 65 Lamotrigine 65 Urine Test 65 Cell Transplant 65 Non Responders 65 Viral Infections 65 Lung Injury 65 Help Diagnose 65 BARACLUDE ® 65 Antiretroviral Drug 65 Lung Tumors 65 R lenalidomide 65 Daptomycin 65 Abortion Pill 65 Potent Inhibitor 65 Novel Vaccine 65 Medoxomil 65 FDA Approves 65 Cutaneous T 65 Adefovir 65 Preclinical Evaluation 65 Allergic Reactions 65 Subtypes 65 Peptic Ulcer 65 Interferon Alfa 65 C1 Inhibitor 65 Hormone Receptor Positive 65 Angioedema 65 Brain Metastases 65 Recombinant Human 65 Liver Tumors 65 Nanoemulsion 65 Respiratory Syncytial Virus RSV 65 Recurrent Glioblastoma 65 Increased Mortality 65 Therapeutic Vaccines 65 Prostate Biopsy 65 Zithromax azithromycin 65 Etanercept 65 Stomach Cancer 65 Cancer Vaccines 65 Carotid Artery Stenting 65 Pulmonary Artery 65 Safinamide 65 Endometrial Cancer 65 Symptom Relief 65 Aflibercept 65 Emergency Contraceptive 65 AVI BioPharma Announces 65 Muscle Function 65 Influenza Vaccine 65 Therapy Shows Promise 65 Maribavir 65 Injection Site 65 Renal Insufficiency 65 Generic Lovenox 65 Immunomodulatory 65 Mg Uk 65 Adjunctive Treatment 65 acyclovir Zovirax 65 Diagnosis Treatment 65 Immunomedics Announces 65 Contrast Agents 65 Adalimumab 65 Prognostic Factors 65 Swine Flu Vaccines 65 Prevent Stroke 65 Submits Biologics License Application 65 J Clin 65 SPRYCEL ® 65 Effective Treatments 65 Chemotherapy Regimen 65 Kidney Failure 65 Stent Thrombosis 65 Irritable Bowel 65 Cethromycin 65 insulin glulisine 65 Enoxaparin 65 Vaccine Adjuvants 65 Respiratory Distress 65 Intravascular 65 #-# Full Text 65 Preterm Labor 65 Antipsychotic Drugs 65 Randomized Phase 65 #k Clearance 65 Immune Cells 65 Randomized Double blind 65 Dose Finding 65 Macrolide 64 Synthetic Peptide 64 Immunotherapeutic 64 Zorbtive TM 64 Study Shows Benefits 64 Orally Disintegrating Tablets 64 Liver Damage 64 Medication Errors 64 Grants Orphan Drug 64 Azacitidine 64 Prostatic 64 Drug Maker 64 Allergic Asthma 64 Levofloxacin 64 Reduced Risk 64 Teriparatide 64 Influenza Vaccine Production 64 Hematological Malignancies 64 Mouse Models 64 Phase III Pivotal 64 adalimumab Humira 64 Pain Medications 64 MEK Inhibitor 64 Bird Flu Vaccine 64 BioSante Pharmaceuticals Reports 64 Nasal Spray 64 Zoloft sertraline 64 Obese Patients 64 TNF Tumor Necrosis Factor 64 Announces Tentative Approval 64 Nesiritide 64 Unfractionated Heparin 64 Vascular Grafts 64 Treatment Regimens 64 Previously Untreated 64 Genital Herpes 64 Hospitalization Rates 64 Successfully Treats 64 AVASTIN 64 Paclitaxel Carboplatin 64 Carotid Stenting 64 Significantly Improves 64 Immunosuppression 64 Radiation Induced 64 Treat Parkinson Disease 64 Renal Cancer 64 Heart Transplant Recipients 64 Medication Adherence 64 vapreotide acetate 64 Birth Defect Risk 64 Treatment Naive 64 Epoetin Alfa 64 Bayer Onyx 64 Commences Phase 64 Leukemia Cells 64 Blood Stem Cells 64 Myocardial Ischemia 64 Ozarelix 64 Immunogenicity 64 RhuDex 64 Antipsychotic 64 hypereosinophilic syndrome 64 Study Shows Promise 64 Ear Infections 64 Anticonvulsant 64 Indomethacin 64 Initiates Dosing 64 Idiopathic Pulmonary Fibrosis 64 POSIDUR TM 64 Significantly Reduces 64 Bone Marrow Cells 64 Antidepressant Drug 64 Parnate 64 Abdominal Pain 64 Viral Load 64 Contrast Agent 64 Migraine Headache 64 metastatic malignant 64 Oncolytic 64 Acute Renal Failure 64 Desvenlafaxine 64 Obesity Linked 64 SBIR Grant 64 Guidelines Recommend 64 Palonosetron 64 Hemorrhagic Stroke 64 Therapeutic Efficacy 64 Anti Inflammatory 64 Blood Pressure Drugs 64 Clinically Proven 64 Bepreve TM 64 Prophylaxis 64 Initiates Clinical Trials 64 Estrogen Receptor 64 Alternative Treatments 64 Treatment Naïve 64 Risedronate 64 J Am Coll 64 TYGACIL 64 Million Milestone Payment 64 Antipsychotic Medications 64 Milestone Payments 64 Patent Covering 64 Clostridium difficile Infection 64 Autoimmune Diseases 64 Decitabine 64 Antibiotic Treatment 64 Entry Inhibitor 64 Antithrombotic 64 Maven Semantic 64 Opioid Addiction 64 Commence Phase 64 Clinical Study Shows 64 Pandemic Vaccine 64 Cases Linked 64 GRAS Status 64 Stent Placement 64 Preclinical Efficacy 64 Treatment Naive HIV 64 Lipid Lowering 64 BARACLUDE R 64 Earns Milestone Payment 64 Partial Seizures 64 Prognostic Value 64 Antiarrhythmic 64 Hepatic Encephalopathy 64 Allogeneic 64 Carboplatin Paclitaxel 64 Ziprasidone 64 Excessive Sweating 64 abacavir Ziagen 64 Cognitive Function 64 Heart Failure Treatment 64 inhalation powder 64 Corticosteroid 64 Telbivudine 64 Diabetic Neuropathic Pain 64 Hydrochlorothiazide Tablets 64 GW# [003] 64 Beta Blockers 64 Pharmacodynamics 64 Study Demonstrates 64 XYOTAX TM 64 Drug Eluting 64 Gene Variants 64 Recurrent Ovarian Cancer 64 Gastrointestinal Disorders 64 Potentially Deadly 64 Budesonide 64 Head Lice Treatment 64 Radiation Dose 64 Iron Deficiency Anemia 64 Taclonex R 64 Versus Placebo 64 Inactivated 64 Eltrombopag 64 Clavulanate 64 Pegylated Liposomal Doxorubicin 64 Controlled Trial 64 Transplant Rejection 64 Oropharyngeal Candidiasis 64 Respiratory Infections 64 Accelerated Approval 64 Patients Enrolled 64 Spectrum Pharmaceuticals Announces 64 k Clearance 64 Trodusquemine MSI 64 Acute Ischemic Stroke 64 Impotence Drug 64 Localized Prostate Cancer 64 Anemia Drugs 64 Glaucoma Treatment 64 Carbidopa Levodopa 64 Implantable Device 64 Dasatinib 64 Tentative Approval 64 Receives Marketing Authorization 64 Zidovudine Tablets 64 Cervical Spine 64 Suppositories 64 See WARNINGS 64 Azathioprine 64 Poster Presentations 64 Boosts Survival 64 Study Evaluates 64 Lowers Blood Pressure 64 Aortic Valve Replacement 64 Hepatotoxicity 64 Gum Disease 64 Androgen Deprivation Therapy 64 Eur J 64 Drug Regimen 64 Spinal Fusion 64 Menopausal Women 64 Hsp# Inhibitor 64 Hernia Repair 64 Clinically Tested 64 Betaferon R 64 VIVUS Qnexa 64 Orally Active 64 PEGylated Fab fragment 64 Tolerability 64 Surgical Procedures 64 Adenoma 64 Nonprescription 64 Skin Lesions 64 Acute Pain 64 ORENCIA ®